These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11008656)

  • 41. "Relatively spared zones" in leprosy: a clinicopathological study of 500 patients.
    Kaur I; Indira D; Dogra S; Sharma VK; Das A; Kumar B
    Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):227-30. PubMed ID: 14608818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Animal models for research in leprosy.
    Kirchheimer WF
    J Med Assoc Thai; 1972 Oct; 55(10):605-9. PubMed ID: 4563001
    [No Abstract]   [Full Text] [Related]  

  • 43. Use of protein antigens for early serological diagnosis of leprosy.
    Duthie MS; Goto W; Ireton GC; Reece ST; Cardoso LP; Martelli CM; Stefani MM; Nakatani M; de Jesus RC; Netto EM; Balagon MV; Tan E; Gelber RH; Maeda Y; Makino M; Hoft D; Reed SG
    Clin Vaccine Immunol; 2007 Nov; 14(11):1400-8. PubMed ID: 17898185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leprosy research declines, but most of the basic questions remain unanswered.
    Scollard DM
    Int J Lepr Other Mycobact Dis; 2005 Mar; 73(1):25-7. PubMed ID: 15898836
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects.
    Havlir DV; Schrier RD; Torriani FJ; Chervenak K; Hwang JY; Boom WH
    J Infect Dis; 2000 Dec; 182(6):1658-63. PubMed ID: 11069237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophage Polarization in Leprosy-HIV Co-infected Patients.
    da Silva TP; Bittencourt TL; de Oliveira AL; Prata RBDS; Menezes V; Ferreira H; Nery JADC; de Oliveira EB; Sperandio da Silva GM; Sarno EN; Pinheiro RO
    Front Immunol; 2020; 11():1493. PubMed ID: 32849508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uveitis seen in the long clinical course of leprosy.
    Namisato M; Kida J; Higashi M; Ogawa H
    Int J Lepr Other Mycobact Dis; 2002 Jun; 70(2):121-4. PubMed ID: 12211897
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunostimulatory activity of major membrane protein-II from Mycobacterium leprae.
    Makino M; Maeda Y; Ishii N
    Cell Immunol; 2005 Jan; 233(1):53-60. PubMed ID: 15885677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allergy and immunity in leprosy: are these concepts becoming obsolete?
    Corcos MG
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):106-9. PubMed ID: 3286796
    [No Abstract]   [Full Text] [Related]  

  • 50. [T and B lymphoid subpopulations in patients with leprosy].
    Finiasz MR; Arias DA; Valdez R; Estevez ME; Sen L
    Medicina (B Aires); 1981; 41 Suppl():131-6. PubMed ID: 7047979
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of preformed immune complexes on the course of Mycobacterium leprae infection in normal mice.
    Kaur S; Vaishnavi C; Kumar B; Ganguly NK
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):358-61. PubMed ID: 3298483
    [No Abstract]   [Full Text] [Related]  

  • 52. [Lysosomes in the pathology of leprosy].
    Kurilov VIa
    Arkh Patol; 1971; 33(4):28-31. PubMed ID: 4945785
    [No Abstract]   [Full Text] [Related]  

  • 53. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person.
    Lawn SD; Wood C; Lockwood DN
    Clin Infect Dis; 2003 Jan; 36(1):e5-6. PubMed ID: 12491222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How to prevent immunological reactions in leprosy patients and interrupt transmission of Mycobacterium leprae to healthy subjects: two hypotheses.
    Mastrangelo G; Marcer G; Cegolon L; Buja A; Fadda E; Scoizzato L; Pavanello S
    Med Hypotheses; 2008 Oct; 71(4):551-63. PubMed ID: 18614293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of mycobacterial antigen responses in lung but not blood in HIV-tuberculosis co-infected subjects.
    Breen RA; Janossy G; Barry SM; Cropley I; Johnson MA; Lipman MC
    AIDS; 2006 Jun; 20(9):1330-2. PubMed ID: 16816564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological significance of changes in lymph nodes across the leprosy spectrum.
    Turk JL; Waters MF
    Clin Exp Immunol; 1971 Mar; 8(3):363-76. PubMed ID: 4930640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. M. leprae and its affinity for nerves.
    Skinsnes OK
    Int J Lepr Other Mycobact Dis; 1971; 39(3):762-5. PubMed ID: 4948225
    [No Abstract]   [Full Text] [Related]  

  • 59. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
    Mohanty KK; Joshi B; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.